
Markets desk · July 23, 2026
Utah Medical Products revenue falls 14.3% in Q2 2026 as two former top customers book zero in sales
Second-quarter revenues for Utah Medical Products, Inc. (Nasdaq: UTMD) fell 14.3% to $8.529 million from $9.953 million a year earlier, the company disclosed Wednesday, with zero sales from two previously top accounts responsible for 75% of the shortfall. The Salt Lake City medic
Latest from the wire
See all bulletins →Top of the hour
Updated July 23, 2026The Wire — newest first
Every bulletin dated and ordered by recency. Older stories fade down the board as fresher ones break.
The alert, before the trend
Don't refresh the feed. Let the feed find you.
Subscribe and we'll send the bulletin the instant our desk confirms it — verified, timestamped, and straight to your inbox.
Subscribe by email